openPR Logo
Press release

Companion Animal Pharmaceuticals Industry Outlook 2025-2029: Market Set to Cross $26.34 Billion Milestone

11-05-2025 05:57 AM CET | Health & Medicine

Press release from: The Business Research Company

Companion Animal Pharmaceuticals Market

Companion Animal Pharmaceuticals Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Companion Animal Pharmaceuticals Market Size By 2025?
In the last few years, there has been significant growth in the market size of companion animal pharmaceuticals. It's expected to increase from $16.49 billion in 2024 to $17.85 billion in 2025, with a compound annual growth rate (CAGR) of 8.2%. This growth during the historic period is a result of factors such as the humanization of pets, the emphasis on preventive healthcare, an increase in pet insurance, shifts in lifestyle and urbanization, concerns about zoonotic diseases, and improved access to veterinary healthcare.

How Big Is the Companion Animal Pharmaceuticals Market Size Expected to Grow by 2029?
The pharmaceuticals market for companion animals is projected to grow significantly in the upcoming years, eventually reaching a market value of $26.34 billion in 2029, reflecting a compound annual growth rate (CAGR) of 10.2%. This growth over the forecast period is expected thanks to several factors such as customized treatments for pets, the emergence of telehealth and remote veterinary services, the emphasis on nutrition and nutraceuticals, one health movements, and the expansion of veterinary diagnostic services. Key trends during this forecast period are expected to include progress in veterinary medicine, specialized treatments for aging pets, maintained regulatory compliance and safety standards, and strategic collaborations and partnerships.

View the full report here:
https://www.thebusinessresearchcompany.com/report/companion-animal-pharmaceuticals-global-market-report

Which Key Market Drivers Powering Companion Animal Pharmaceuticals Market Expansion and Growth?
The rising incidence of diseases that can be naturally transmitted from animals to humans, known as zoonotic diseases, is anticipated to significantly boost the expansion of the companion animal pharmaceuticals market. To efficiently fight zoonotic diseases and reduce the chances of their spread, the pharmaceutical sector is adopting innovative approaches which are aligned with a unique health protocol. For instance, a report from the European Centre for Disease Prevention and Control indicated that in December 2022, Campylobacteriosis was reported as the prevalent zoonotic disease in Sweden, with the number of cases dramatically increasing to 127,840 in 2022. The majority of these cases were linked to chicken and turkey meat. Following this, Salmonella was identified as the second widespread zoonotic disease, infecting 60,050 individuals. Yersiniosis (6,789 cases), Shigatoxin-producing E. coli infections (6,084 cases), and Listeriosis (2,183 cases) in order followed. Hence, the escalating incidence of zoonotic diseases is fueling the growth of the companion animal pharmaceuticals market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7983&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Companion Animal Pharmaceuticals Market?
The adoption of big data technologies is becoming a prominent trend in the companion animal pharmaceuticals industry. To solidify their market position, key companies are focusing on the creation of innovative technological solutions. For instance, in April 2022, Elanco Animal Health Incorporated and Ginkgo Bioworks, both US-based companies in the companion animal pharmaceuticals domain, introduced BiomEdit, a pioneering company specializing in microbiome. This development aims to generate groundbreaking advancements in animal health, including new probiotics and other related animal pharmaceutical products. Among the proposed innovations are medicated feed ingredients, nutritional health therapies for livestock and domestic pets, and advanced biosecurity technologies for monitoring animal diseases.

What Are the Emerging Segments in the Companion Animal Pharmaceuticals Market?
The companion animal pharmaceuticals market covered in this report is segmented -

1) By Animal Type: Dogs, Cats, Horses, Other Companion Animals
2) By Indication: Infectious Diseases, Dermatologic Diseases, Pain, Orthopedic Diseases, Behavioral Diseases, Other Indications
3) By Distribution Channels: Veterinary Hospitals, Veterinary Clinics, Retail Pharmacies

Subsegments:
1)By Dogs: Vaccines, Antiparasitic, Anti-Inflammatory Drugs
2) By Cats: Vaccines, Antiparasitic, Anti-Inflammatory Drugs
3) By Horses: Vaccines, Antiparasitic, Anti-Inflammatory Drugs
4) By Other Companion Animals: Vaccines, Antiparasitic, Other Therapeutics

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=7983&type=smp

Who Are the Global Leaders in the Companion Animal Pharmaceuticals Market?
Major companies operating in the companion animal pharmaceuticals market are Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, Ceva Santé Animale, Chanelle Pharma, Eco Animal Health Group PLC, Ashish Life Science Pvt. Ltd., Endovac Animal Health, Hipra Laboratories, Indian Immunologicals Ltd., Inovet Group, Kyoritsu Seiyaku Corporation, Lutim Pharma Pvt. Ltd., Merck & Co. Inc., Norbrook Laboratories Ltd., Tianjin Ringpu Bio-Technology Co. Ltd., Vetoquinol S.A., Virbac S.A., Zoetis Inc., Agrolabo S.p.A., ALS Pvt. Ltd., Zydus Animal Health and Investments Limited, Eli Lilly and Company, IDEXX Laboratories Inc., Merial Limited, Novartis Animal Health Inc., Dechra Pharmaceuticals PLC, Aratana Therapeutics Inc., Phibro Animal Health Corporation, Kindred Biosciences Inc., Jaguar Health Inc., Nexvet Biopharma PLC, Sentinel Biomedical Inc., PetMed Express Inc., Neogen Corporation, Heska Corporation, Synbiotics Corporation, Eurovet Animal Health B.V., Vironova AB, Abaxis Inc., Bioiberica S.A.U., Putney Inc., Lohmann Animal Health International

Which are the Top Profitable Regional Markets for the Companion Animal Pharmaceuticals Industry?
North America was the largest region in the companion animal pharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the companion animal pharmaceuticals market report during the forecast period. The regions covered in the companion animal pharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7983

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Companion Animal Pharmaceuticals Industry Outlook 2025-2029: Market Set to Cross $26.34 Billion Milestone here

News-ID: 4254119 • Views:

More Releases from The Business Research Company

Emerging Trends to Reshape the Veterinary Infectious Disease Diagnostics Market: Growing Technological Advances In Veterinary Diagnostics as a Key Influencer
Emerging Trends to Reshape the Veterinary Infectious Disease Diagnostics Market: …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Veterinary Infectious Disease Diagnostics Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In recent times, the market size of veterinary infectious disease diagnostics has seen robust growth. The projections suggest a growth from $1.93 billion in 2024 to $2.11 billion in 2025, indicating a compound
2025-2034 Farm Animal Healthcare Market Outlook: Key Drivers, Emerging Challenges, and Strategic Insights
2025-2034 Farm Animal Healthcare Market Outlook: Key Drivers, Emerging Challenge …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Farm Animal Healthcare Industry Market Size Be by 2025? There has been a significant increase in the size of the farm animal healthcare market in the past few years. The market is projected to expand from $21.02 billion in 2024 to $22.33 billion in 2025, with
Future of Military Deployable Infrastructure Market: Size, Share & Forecasts to 2029
Future of Military Deployable Infrastructure Market: Size, Share & Forecasts to …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports. What Is the Projected Market Size Valuation of the Military Deployable Infrastructure Market by 2025? The market size for military deployable infrastructure has seen a firm increase in recent times. It is predicted to expand from $0.95 billion in 2024 to reach $1.01 billion in 2025, achieving a compound annual growth
Aerospace and Industrial Ignition Systems and Aircraft Ignition System Industry to Achieve $3.7 Billion Growth by 2029
Aerospace and Industrial Ignition Systems and Aircraft Ignition System Industry …
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments. How Will the Aerospace and Industrial Ignition Systems and Aircraft Ignition System Market Grow by 2025 in Terms of Size and Growth? The market size for aerospace and industrial ignition systems, including aircraft ignition systems, has seen significant growth recently. The market is projected to increase from $2.62 billion in 2024 to

All 5 Releases


More Releases for Animal

Animal Health Market Sets the Table for Continued Growth : Zoetis Animal Healthc …
Advance Market Analytics published a new research publication on "Animal Health Market Insights, to 2028" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Animal Health market was mainly driven by the increasing R&D spending across the world. Some of the key players profiled
Animal Antimicrobials and Antibiotics Market 2023 Growth and Development By Bion …
Antibiotics, also called antibacterials, are a type of antimicrobial drug used in the treatment and prevention of bacterial infections. They may either kill or inhibit the growth of bacteria. Animal Antimicrobials and Antibiotics includes Premixes, Oral Powders, Oral Solutions and Injections on the base of classification, which represent 12.4%, 14.4%, 10.4% and 56.6% of global Animal Antimicrobials and Antibiotics market. Get Sample Copy: https://www.worldwidemarketreports.com/sample/273708 Farm Animals and Companion Animals are the
Animal Healthcare Market Analysis Focusing on Top Key Players - Merck, Bayer Ani …
Worldwide Market Reports recently released on the Animal Healthcare market for the forecast period, 2017 – 2022 is involved in screening the business environment and the companies operating in the Animal Healthcare industry. Importantly, the research sheds a lot of light on their winning strategies to help stakeholders, business owners, and field marketing executives stay ahead in the competition. Besides, the industry is thoroughly weighed upon on the basis of
Animal Model Market trends, Animal Model Market growth, Animal Model Market size …
Key Findings of Animal Model Market Developing Regions to Overpower Developed Ones With Regard to Demand The Asian territory is on the verge of evolving as the next big destination for animal models. This growth can be attributed to various factors such as American and European pharmaceutical companies diversifying their research activities to curtail extra expenses and save costs. Although U.S and Europe have retained their legacy in the global market, their
Animal Growth Promoter Market Outlook To 2023 – Bayer Animal Health, Biomin, B …
Nov 2018, New York USA (News)- Different categories of feed additives for farm animals are referred to as natural growth promoters (NGPs) or non-antibiotic growth promoters. They are commonly regarded as favorable alternatives to antibiotic growth promoters (AGPs) in livestock production. NGPs include predominantly organic acids, probiotics, prebiotics, synbiotics, phytogenics, tannins, feed enzymes and immune stimulants, an ongoing search for alternatives has created a large variety of NGPs for pigs,
Animal Antimicrobials and Antibiotics Market Key Players : Animal Health, Bayer …
The term antibiotic or antimicrobial is used for those agents who kill or inhibit the growth of microorganism. The antimicrobials products have significant benefits to the animal and to human food safety. There are researches, which have proven that an increase in the rate of animal illness results in higher rate of human illness. Therefore, livestock dealers depend on animal antibiotics to provide safe food. The scope of this report